Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

USANA Health Sciences, Inc. USNA

Consumer Defensive  —  Packaged Foods
14.50 0.24 1.68% as of 25 Sep
Market cap
$263.5M
P/E
0.0×
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio 0.00 37.17 35.69 31.31

+8 more quarters
P/S ratio 0.43 0.35 0.39 0.55
P/FCF ratio 19.83 46.49 29.27 26.96
P/Operating CF 16.93 32.94 (107.33) (257.00)
P/B ratio 0.75 0.59 0.68 0.95
Price to Tangible BV 1.35 1.16 1.39 2.05
EV/Sales 0.26 0.18 0.23 0.40
EV/EBITDA 3.48 2.21 2.75 4.74
EV/Operating CF 8.40 9.96 9.50 11.59
EV/FCF 11.71 23.94 17.08 19.55
Quick Ratio 1.63 1.47 1.27 1.22
Current Ratio 2.66 2.51 2.24 2.23
Net Debt/EBITDA (9.21) (6.88) (11.23) (13.47)
Debt/Assets 0.00% 0.00% 0.00% 0.00%
Debt/Equity 0.00 0.00 0.00 0.00
Asset Turnover 1.27 1.25 1.24 1.31
Operating CF/Net income (1.09) 1.30 1.91 0.30
Capex/Depreciation (0.08) (0.27) 0.11 (0.33)
Interest Coverage 0.00 0.00 0.00 0.00
Research and Development Expense of Revenue 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue 74.26% 70.70% 73.39% 76.58%
Intangible Assets out of Total Assets 0.33 0.36 0.36 0.39
Share Based Compensation of Revenue 1.52% 1.38% 1.66% 1.67%
Graham Net Nets 0.26 0.31 0.22 0.13
Graham Number 0.00 17.68 18.87 23.91
Earnings Yield (5.67%) 2.69% 2.80% 3.19%
Free Cash Flow Yield 5.04% 2.15% 3.42% 3.71%
Revenue per Share 12.08 13.60 12.20 11.68
Operating CF per Share 1.26 0.53 (0.18) (0.11)
Capex per Share (0.17) (0.14) 0.06 (0.17)
Free Cash Flow per Share 1.09 0.39 (0.12) (0.28)
Cash per Share 9.12 8.85 8.54 7.95
Shareholders Equity per Share 28.47 29.54 28.76 28.87
Interest Debt per Share 0.00 0.00 0.00 0.00
Book value per Share 28.47 29.54 28.76 28.87
Free Cash Flow 20.18 7.16 (2.28) (5.16)
Working Capital 175.39 176.99 159.84 145.40
Capital Expenditures (3.14) (2.60) 1.11 (3.20)
Net Current Asset Value 104.16 98.82 78.59 65.55
EV/EBIT 0.00 4.65 5.67 8.74
Capex to Sales 0.01 0.01 0.00 0.02
Net Profit Margin (9.58%) 3.00% (0.78%) (3.05%)
Price to Operating Income 0.00 9.02 9.72 12.05
Other line items
Average Receivables 5.25 8.54 6.52 —
Average Payables 16.67 15.10 14.62 11.63
Average Inventory 84.81 84.96 86.17 77.38
Average Assets 718.87 742.78 745.55 698.95
Average Common Equity 528.68 536.66 532.61 530.58

Fold the line items

Columns are period end dates